Average Co-Inventor Count = 2.85
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sugen Incorporated (19 from 157 patents)
2. Exelixis, Inc. (8 from 175 patents)
3. Genentech, Inc. (6 from 3,222 patents)
4. Bristol-myers Squibb Compnay (5 from 3,684 patents)
5. Oncogen (3 from 48 patents)
6. Other (1 from 832,843 patents)
7. Eli Lilly and Company (1 from 4,446 patents)
8. Immunogen, Inc. (1 from 255 patents)
9. Zymeworks Inc. (1 from 56 patents)
10. Imclone LLC (1 from 26 patents)
11. F. Hoffmann-la Roche Ag (168 patents)
44 patents:
1. 11203640 - Checkpoint inhibitor bispecific antibodies
2. 9375488 - Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment
3. 9284376 - Antibodies
4. 8962275 - Anti-α5β1 antibodies and uses thereof
5. 8840887 - Antibodies
6. 8771942 - SCDs as modifiers of the p53 pathway and methods of use
7. 8350010 - Anti-alpha5/beta1 antibody
8. 8268548 - MAP3Ks as modifiers of the p53 pathway and methods of use
9. 8153384 - Marks as modifiers of the p53 pathway and methods of use
10. 8124740 - Anti- α5 β1 antibodies and uses thereof
11. 8105785 - Mylks as modifiers of branching morphogenesis and methods of use
12. 7993829 - HPRP4s modifiers of the p53 pathway and methods of use
13. 7973138 - Antibodies
14. 7119174 - Diagnosis and treatment of AUR1 and/or AUR2 related disorders
15. 7115710 - Diagnosis and treatment of PTP related disorders